Daniel L Kisner is Director of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 23,329 shares of DVAX, which is worth approximately $260,351. The most recent transaction as insider was on Jun 11, 2025, when has been sold 5,758 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.3K
32.77% 3M change
32.77% 12M change
Total Value Held $260,351

DANIEL L KISNER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 11 2025
BUY
Grant, award, or other acquisition
-
5,758 Added 19.8%
23,329 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
5,357 Added 23.36%
17,571 Common Stock
May 26 2023
BUY
Grant, award, or other acquisition
-
5,357 Added 30.49%
12,214 Common Stock

Also insider at

HSTO
Histogen Inc. Healthcare
ONCT
Oncternal Therapeutics, Inc. Healthcare
ZYNE
Zynerba Pharmaceuticals, Inc. Healthcare
DLK

Daniel L Kisner

Director
Emeryville, CA

Track Institutional and Insider Activities on DVAX

Follow DYNAVAX TECHNOLOGIES CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVAX shares.

Notify only if

Insider Trading

Get notified when an Dynavax Technologies Corp insider buys or sells DVAX shares.

Notify only if

News

Receive news related to DYNAVAX TECHNOLOGIES CORP

Track Activities on DVAX